ScholarIQanswers from OpenAlex

Outcome of COVID-19 patients with use of Tocilizumab: A single center experience

PaperCitations, authors & open-access status

Outcome of COVID-19 patients with use of Tocilizumab: A single center experience is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Outcome of COVID-19 patients with use of Tocilizumab: A single center experience have?

ScholarIQcitation count

Outcome of COVID-19 patients with use of Tocilizumab: A single center experience has 23 citations in the OpenAlex counts ScholarIQ stores.

When was Outcome of COVID-19 patients with use of Tocilizumab: A single center experience published?

ScholarIQyear

Outcome of COVID-19 patients with use of Tocilizumab: A single center experience has 2020 year in the ScholarIQ index.

What is the open-access status of Outcome of COVID-19 patients with use of Tocilizumab: A single center experience?

ScholarIQoa status

Outcome of COVID-19 patients with use of Tocilizumab: A single center experience has green oa status in the ScholarIQ index.

What is the DOI of Outcome of COVID-19 patients with use of Tocilizumab: A single center experience?

ScholarIQdoi

The DOI for Outcome of COVID-19 patients with use of Tocilizumab: A single center experience is on the source record.

What is the PMID of Outcome of COVID-19 patients with use of Tocilizumab: A single center experience?

ScholarIQpmid

The PMID for Outcome of COVID-19 patients with use of Tocilizumab: A single center experience is on the source record.

What is the OpenAlex record for Outcome of COVID-19 patients with use of Tocilizumab: A single center experience?

ScholarIQopenalex

The OpenAlex for Outcome of COVID-19 patients with use of Tocilizumab: A single center experience is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial